The VIVA Clinical Trial (Vaccine to Interrupt Progression of Vulvar and Anal Neoplasia) will test whether the Human Papillomavirus (HPV) vaccine can improve the health of people who have been previously diagnosed with pre-cancerous lesions.
Category: Past Studies
More: Past Studies
VRC studies over the decades
HSV and HIV Tissue Reservoirs Study
The purpose of this study is to understand whether immune responses to herpes simplex virus type 2 bring HIV infected cells to the genital tract in people with HIV infection. The study will last for 5 months and involve 8 clinic visits.
Novavax COVID-19 Vaccine Trial
This is a clinical trial of a Phase 3 vaccine for the prevention of COVID-19. Our research site is testing the SARS-CoV-2 recombinant spike protein nanoparticle vaccine that is now being developed as part of Operation Warp Speed by a new NIH network – the Coronavirus Prevention Network, or CoVPN – and Novavax as the pharmaceutical partner.